Table 1 Campylobacter recovery, sequence types and antimicrobial resistance in stool specimens of four patients
From: Comparative genomics of Campylobacter jejuni from clinical campylobacteriosis stool specimens
Patient identifier (total number isolates cultured) | Culture method (n) | Campylobacter species (n) | MLST (n) | Acquired resistance gene | Chromosomal point mutation | ||
|---|---|---|---|---|---|---|---|
Resistance gene profile (n) | Predicted resistance phenotype (n) | gyrA mutation (n) | Predicted resistance phenotype (n) | ||||
Patient 1 (n = 30) | Direct (15) | C. jejuni (15) | ST-61 (15) | blaOXA-61 (15) | Ampicillin (15) | – | – |
Filtered (15) | C. jejuni (15) | ST-61 (15) | blaOXA-61 (15) | Ampicillin (15) | – | – | |
Patient 2 (n = 23) | Direct (9) | C. jejuni (9) | ST-2066 (9) | tet(O) (9) | Tetracycline (9) | T86I (9) | Quinolone (9) |
Filtered (14) | C. jejuni (14) | ST-2066 (14) | tet(O) (14) | Tetracycline (14) | T86I (14) | Quinolone (14) | |
Patient 3 (n = 13) | Direct (0) | – | – | – | – | – | – |
Filtered (13) | C. jejuni (12), C. jejuni (1) | ST-51 (12), ST-354 (1) | blaOXA-61, tet(O) (12), blaOXA-61, tet(O) (1) | Ampicillin, Tetracycline (12), Ampicillin, Tetracycline (11) | T86I (1) | Quinolone (1) | |
Patient 4 (n = 26) | Direct (13) | C. jejuni (13) | ST-21 (13) | blaOXA-61 (13) | Ampicillin (13) | T86I (13) | Quinolone (13) |
Filtered (13) | C. jejuni (13) | ST-21 (13) | blaOXA-61 (13) | Ampicillin (13) | T86I (13) | Quinolone (13) | |